EUROMACS Right Ventricular Failure (RHF) Risk Score Calculator

Clinical calculation support · Verify results before clinical use

Risk assessment

Enter preoperative variables for patients being evaluated for continuous-flow LVAD implantation.

0Points

Use the measured preoperative value.

Must be greater than zero to calculate the RAP/PCWP ratio.

Score criterion: hemoglobin ≤10 g/dL.

This implementation applies the source-code threshold of ≥3 agents; see the clinical audit note below.

Select profile 1–7.

Use the preoperative echocardiographic assessment.

—EUROMACS-RHF
Risk category
Awaiting inputs
Complete all required fields, then calculate.
Clinical interpretation

This score estimates risk of early severe right heart failure after LVAD implantation. It is an adjunct to multidisciplinary clinical assessment, not a standalone decision rule.

VariableEntered valuePoints
Score breakdown will appear after calculation.

Risk estimates are cohort-level estimates from the derivation study and may not be calibrated to a particular centre or contemporary LVAD population.

About the EUROMACS-RHF score

The EUROMACS Right-Sided Heart Failure score was developed to estimate early (within 30 days) severe right-sided heart failure after continuous-flow LVAD implantation. The published preoperative score uses five variables; cardiopulmonary bypass time is not part of this preoperative score.

Scoring criteria

VariableCriterionPoints
RAP/PCWP ratio>0.54+2
Hemoglobin≤10 g/dL+1
Intravenous inotropesMultiple agents; implementation threshold currently ≥3+2.5
INTERMACS profile1–3+2
Severe RV dysfunctionPresent on preoperative echocardiography+2

Risk groups

ScoreCategoryReported early RHF risk
0–2LowApproximately 11%
>2–4IntermediateApproximately 25–28% (reported across cohorts)
>4HighUp to approximately 43%

References

Soliman OII, et al.; EUROMACS Investigators.Derivation and Validation of a Novel Right-Sided Heart Failure Model After Implantation of Continuous Flow Left Ventricular Assist Devices. Circulation. 2018;137:891–906. doi:10.1161/CIRCULATIONAHA.117.030543. PMID: 28847897.
External assessment of the EUROMACS right-sided heart failure risk score.Scientific Reports. 2021. External validation found poor discrimination in that cohort (AUC 0.58), underscoring limitations in transportability. Read publication.
Prediction of right heart failure after left ventricular assist implantation: external validation of the EUROMACS-RHF score.European Heart Journal: Acute Cardiovascular Care. 2021. Reported AUC 0.64 in an external cohort. Read publication.
Clinical disclaimer: For educational and decision-support use only. The score must not replace clinical judgement, haemodynamic interpretation, echocardiography, or multidisciplinary LVAD-team assessment. External validation studies report variable discrimination; do not interpret cohort risk bands as an individualized probability with guaranteed calibration.